SIGNIFICANT DIFFERENCE IN THE PROPORTION OF UNDERLYING DISEASES BETWEEN CONVENTIONAL PROTON PUMP INHIBITORS AND VONOPRAZAN REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE.

被引：0
|
作者：
Hamada, Shohei
Ihara, Eikichi
Muta, Kazumasa
Ikeda, Hiroko
Mukai, Kouzi
Otsuka, Yoshihiro
Hata, Yoshitaka
Ogino, Haruei
Chinen, Takatoshi
Ogawa, Yoshihiro
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1201
引用
收藏
页码：S305 / S306
页数：2
相关论文
共 50 条
  • [31] Economic Impact of Proton-Pump Inhibitors in Patients With Refractory Gastroesophageal Reflux Disease: A Managed Care Perspective
    Fu, An-Chen
    Mody, Reema
    Gerson, Lauren B.
    Tan, Hiangkiat
    GASTROENTEROLOGY, 2013, 144 (05) : S205 - S205
  • [32] The parameters on esophageal pH-impedance testing in patients with gastroesophageal reflux disease refractory to proton pump inhibitors
    Evsyutina, Y.
    Trukhmanov, A.
    Storonova, O.
    Ivashkin, V.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 : 58 - 58
  • [33] Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors
    Edy Soffer
    Leonardo Rodríguez
    Patricia Rodriguez
    Beatriz Gómez
    Manoel G Neto
    Michael D Crowell
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2016, 7 (01) : 145 - 155
  • [34] Histology of symptomatic gastroesophageal reflux disease: Is it predictive of response to proton pump inhibitors?
    Miwa, Hiroto
    Takubo, Kaiyo
    Shimatani, Tomohiko
    Furuta, Takahisa
    Oshima, Tadayuki
    Tanaka, Junji
    Aida, Junko
    Ito, Masanori
    Kurosawa, Susumu
    Joh, Takashi
    Wada, Tsuneya
    Habu, Yasuki
    Watanabe, Yusuke
    Hongo, Michio
    Chiba, Tsutomu
    Kinoshita, Yoshikazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) : 479 - 487
  • [35] Comparative Safety and Efficacy of Proton Pump Inhibitors in Paediatric Gastroesophageal Reflux Disease
    Kierkus, Jaroslaw
    Oracz, Grzegorz
    Korczowski, Bartosz
    Szymanska, Edyta
    Wiernicka, Anna
    Woynarowski, Marek
    DRUG SAFETY, 2014, 37 (05) : 309 - 316
  • [36] COST ANALYSIS OF PROTON PUMP INHIBITORS IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN UKRAINE
    Iakovlieva, L.
    Gerasymova, O.
    Mishchenko, O.
    Bezditko, N.
    Kyrychenko, O.
    Kuznetsov, I
    VALUE IN HEALTH, 2015, 18 (07) : A623 - A624
  • [37] FACTORS AFFECTING EFFICACY OF GASTROESOPHAGEAL REFLUX DISEASE TREATMENT WITH PROTON PUMP INHIBITORS
    Lazebnik, L. B.
    Bordin, D. S.
    Masharova, A. A.
    Firsova, L. D.
    Silvestrova, S. Yu.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (02) : 16 - 21
  • [38] Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease
    Shi, Yichao
    Li, Jianfeng
    Cai, Shuntian
    Zhao, Hong
    Zhao, Huijun
    Sun, Gang
    Yang, Yunsheng
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [39] Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors
    Hershcovici, Tiberiu
    Fass, Ronnie
    CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (04) : 367 - 378
  • [40] Comparative Safety and Efficacy of Proton Pump Inhibitors in Paediatric Gastroesophageal Reflux Disease
    Jaroslaw Kierkus
    Grzegorz Oracz
    Bartosz Korczowski
    Edyta Szymanska
    Anna Wiernicka
    Marek Woynarowski
    Drug Safety, 2014, 37 : 309 - 316
12345